Authors' reply

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7002.451b (Published 12 August 1995) Cite this as: BMJ 1995;311:451
  1. Marie Doona,
  2. J Bernard Walsh
  1. Registrar Consultant physician Department of Medicine for the Elderly, St James's Hospital, Dublin 8, Republic of Ireland

    EDITOR,--We take issue with several of the points raised in the letters in response to our editorial. R J Mulla and colleagues acept that after systemic use of chloramphenicol the risk of aplastic anaemia is 13 times higher than that in the general population. Yet we know that topical ophthalmic chloramphenicol is absorbed systemically1 and that the development of aplastic anaemia is an …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription